Travelers could soon have more options to get where they're going, thanks to new train routes. To help you understand what is going on and what we expect to happen in the future, our highly-experienced Kiplinger Letter team will keep you abreast of the latest developments and forecasts (Get a free issue of The Kiplinger Letter or subscribe). You'll get all the latest news first by subscribing, but we will publish many (but not all) of the forecasts a few days afterward online. Here’s the latest...
Here’s something that would have sounded impossible until just recently: Privately owned passenger rail is making a comeback in the U.S. A route operated by Brightline, backed by private equity giant Fortress Investment Group, is already in operation between Miami and West Palm Beach. Service will expand to Orlando starting in September, with the $6 billion project linking the theme parks in central Florida with the two fast-growing metros in the southern part of the state.
Beyond Florida, Brightline has big plans in the West, with a $12 billion line between Los Angeles and Las Vegas. Construction is expected to take four years. The firm seeks to control costs by building along existing highway rights-of-way.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
By contrast, California’s troubled high-speed rail project is nowhere near completion of its planned Los Angeles-to-San Francisco service and has ballooned in cost. Brightline has received some federal transportation funding. But the company says that it can pioneer the comeback of private rail service largely with private dollars.
This forecast first appeared in The Kiplinger Letter, which has been running since 1923 and is a collection of concise weekly forecasts on business and economic trends, as well as what to expect from Washington, to help you understand what’s coming up to make the most of your investments and your money. Subscribe to The Kiplinger Letter.
Related Content
- A Rail Stock for the Long Haul
- 24 Best Travel Websites to Find Deals and Save You Money
- 13 Best Infrastructure Stocks for America's Big Building Spend
- Construction Sector Sees Backlogs and Year-Over-Year Declines: Kiplinger Economic Forecasts
- Is Travel Finally Back? New Report Reveals Record Tourism Rebound
- How to Budget for a Vacation When Prices Keep Rising
-
Investments In U.S.-Made Drone Technology Are Gaining Strength — The Kiplinger LetterThe Kiplinger Letter The U.S.-Made drone aircraft, software sector has been boosted by a crackdown on Chinese drones amid security concerns.
-
Auto Industry’s Electric Transition Sparks Tension With Autoworkers: The Kiplinger Letter
The Kiplinger Letter DoE announces $12 billion to support factory retrofits, which autoworkers fear may mean the end of numerous auto manufacturing jobs.
-
Will the U.S. Dodge a Recession?: Kiplinger Economic Forecasts
Kiplinger Economic Forecasts The labor market is healthy enough to dodge a recession, even though job growth is lethargic.
-
Don't Overlook Tax on Crypto Staking Rewards: Kiplinger Tax Letter
Tax Letter The IRS has issued guidance on crypto staking rewards, but broker reporting on digital asset sales won't start until 2025.
-
When Should You Buy Life Insurance?
insurance If no one depends on your income for support, you probably don't need life insurance at all.
-
Falling Prices in China Could Be a Boon For the U.S.: Kiplinger Economic Forecasts
Economic Forecasts Falling prices in China could be a boon for the U.S. as the country's weakened economy shows no clear signs of improvement.
-
Domestic Airfare Is Still Cheaper Than Pre-Pandemic Prices: Kiplinger Economic Forecasts
Economic Forecasts Although domestic airfare is cheaper, some international flights are still more expensive than usual.
-
Five Reasons Your Healthcare Costs Will Ease: Kiplinger Economic Forecasts
Economic Forecasts From technical advancements to cheaper drugs, healthcare cost relief is coming.
